Virtual reality could open doors to trauma therapy

NCT ID NCT06684977

First seen Aug 17, 2026 · Last updated Aug 17, 2026

Summary

This study tests whether low-cost virtual reality (VR) tools, like 360° video and a new VR Photoscan process, can help people with post-traumatic stress disorder (PTSD) engage more easily with trauma-focused therapy. Participants will receive standard therapy (TF-CBT) either alone or with the addition of a personalized VR environment designed to help them revisit and process traumatic memories. The goal is to see if this approach is feasible and acceptable to patients and therapists, potentially making VR a practical tool in routine mental health care.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
Low-cost virtual reality environments using 360° video or VR Photoscan, used alongside standard trauma-focused cognitive behavioural therapy (TF-CBT)
What this could lead to
If this works, it could offer a low-cost, practical way to help people with PTSD engage more easily with trauma-focused therapy, potentially improving treatment outcomes.
What could go wrong
This is a very small feasibility study with only 15 participants, so results may not apply broadly. The technology may not be acceptable or effective for everyone, and there are risks like motion sickness or discomfort.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for PTSD - POST TRAUMATIC STRESS DISORDER are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • South Eastern Health and Social Care Trust (Regional Trauma Network)

    Belfast, Dundonald, BT16 1RH, United Kingdom

More trials for these conditions

Other studies related to the condition(s) this trial covers.